NovoBind Livestock Therapeutics - About the company
NovoBind Livestock Therapeutics is a series A company based in Vancouver (Canada), founded in 2012 by Hamlet Abnousi, Slade Loutet, Filip Van Petegem and Sylvia Cheung. It operates as a Manufacturer and supplier of biological products for animal health protection. NovoBind Livestock Therapeutics has raised an undisclosed amount in funding from investors like Seventure Partners, Lallemand and The Center for Aquaculture Technologies. The company has 19 active competitors, including 4 funded and 1 that has exited. Its top competitors include companies like Benchmark Holdings, Carus Laboratories and Proteon Pharmaceuticals.
Company Details
Manufacturer and supplier of biological products for animal health protection. The company is developing next-generation biologics that target and neutralize the specific bacteria, viruses, and parasites that cause intestinal ailments in livestock, aquaculture, and pets.
- Website
- www.novobind.com/
- Email ID
- *****@novobind.com
- Registered Address
- 13 Mission Avenue, St. Albert
Key Metrics
Founded Year
2012
Location
Vancouver, Canada
Stage
Series A
Latest Funding Round
Investors
Ranked
5th among 19 active competitors
Employee Count
11 as on Jul 01, 2024
Similar Companies
Legal entities associated with NovoBind Livestock Therapeutics
NovoBind Livestock Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Novobind Livestock Therapeutics Inc. CIN: 831171-4 , Canada, Active | Sep 27, 2012 | - | - | - |
Sign up to download NovoBind Livestock Therapeutics' company profile
NovoBind Livestock Therapeutics's funding and investors
NovoBind Livestock Therapeutics has raised funding over 1 round. Its latest funding round was a Series A round on Feb 19, 2020 for $*****. 7 investors participated in its latest round. NovoBind Livestock Therapeutics has 10 institutional investors.
Here is the list of recent funding rounds of NovoBind Livestock Therapeutics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 19, 2020 | 3095658 | Series A | 3099181 | 2523066 | 9506988 | 6983174 |
View details of NovoBind Livestock Therapeutics's funding rounds and investors
NovoBind Livestock Therapeutics' founders and board of directors
Founder? Claim ProfileThe founders of NovoBind Livestock Therapeutics are Hamlet Abnousi, Slade Loutet, Filip Van Petegem and Sylvia Cheung. Hamlet Abnousi is the CEO of NovoBind Livestock Therapeutics.
Here are the details of NovoBind Livestock Therapeutics' key team members:
- Hamlet Abnousi: Co-Founder & CEO of NovoBind Livestock Therapeutics. They serve on the board of 1 company.Contact Info: 1 email address
- Slade Loutet: Co-Founder of NovoBind Livestock Therapeutics. Contact Info: 1 email address
- Filip Van Petegem: Co-Founder of NovoBind Livestock Therapeutics.
- Sylvia Cheung: Co-Founder of NovoBind Livestock Therapeutics. Contact Info: 1 email address
NovoBind Livestock Therapeutics' Board of Directors
NovoBind Livestock Therapeutics's board has 5 active members. Hamlet Abnousi, Robert Allan Fraser, Donald Willoughby, Mitchell Abrahamsen and Nicholas Bedford are independent board members.Here is the list of NovoBind Livestock Therapeutics' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 13y 5m | |
ghtjns{ | Independent board member | - | Current | 6y 9m |
maycjyi | Independent board member | - | Current | 4y 7m |
vqior{s | Independent board member | - | Current | 6y 1m |
ilwcjel | Independent board member | - | Current | 8y 7m |
NovoBind Livestock Therapeutics' employee count trend
NovoBind Livestock Therapeutics has 11 employees as of Jul 24. Here is NovoBind Livestock Therapeutics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NovoBind Livestock Therapeutics's Competitors and alternates
Top competitors of NovoBind Livestock Therapeutics include Benchmark Holdings, Carus Laboratories and Proteon Pharmaceuticals. Here is the list of Top 10 competitors of NovoBind Livestock Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Benchmark Holdings 2000, Sheffield (United Kingdom), Public | Aquaculture biotechnology company | - | 62/100 | |
2nd | Carus Laboratories 2006, Karnal (India), Unfunded | Provider of veterinary feed supplements | - | - | 45/100 |
3rd | Proteon Pharmaceuticals 2005, Lodz (Poland), Series B | Developer of bacteriophage-based products for livestock farming and aquaculture health | $28.8M | 43/100 | |
4th | Peptobiotics 2021, Singapore (Singapore), Series A | Manufacturer of peptides-based livestock feed additives | $6.2M | 42/100 | |
5th | NovoBind Livestock Therapeutics 2012, Vancouver (Canada), Series A | Manufacturer and supplier of biological products for animal health protection | - | 38/100 | |
6th | Essential Aquatech 2019, Jalpaiguri (India), Unfunded | Provider of health solutions for the aquaculture industry | - | - | 31/100 |
7th | Anifera 2020, United Kingdom, Seed | Provider of antibiotic detection and control solutions for livestock | - | 28/100 | |
8th | Maxx Performance 2004, Roanoke (United States), Unfunded | Provider of antibiotic substitutes for the treatment of various diseases in livestock animals | - | - | 28/100 |
9th | Provider of fish health services including detection, understanding, and action points | - | - | 28/100 | |
10th | Provider of preventive treatment for infections in fish | - | - | 24/100 |
Looking for more details on NovoBind Livestock Therapeutics's competitors? Click here to see the top ones
NovoBind Livestock Therapeutics's Investments and acquisitions
NovoBind Livestock Therapeutics has made no investments or acquisitions yet.
Reports related to NovoBind Livestock Therapeutics
Here is the latest report on NovoBind Livestock Therapeutics's sector:
Are you a Founder ?
FAQs about NovoBind Livestock Therapeutics
Explore our recently published companies
- Smart Roumu - Chuo based, 2009 founded, Acquired company
- Celebrationchurchsalinas - Unfunded company
- Eka - 2001 founded, Unfunded company
- Freshroastedhosting - Harrisburg based, 2011 founded, Unfunded company
- Danumsinar - Unfunded company
- Abbisfarmltd - 2018 founded, Unfunded company